Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients

Mohamed Bakr Zaki,1 Ahmed Ibrahim Abulsoud,1,2 Ahmed Mohamed Elsisi,2,3 Ahmed Soliman Doghish,2,4 Ossama Abd Elmotaal Mansour,2 Ashraf Ismail Amin,5 Mahmoud Ahmed Elrebehy,4 Mohamed Yousef Mohamed,6 Mohamed Ahmed Goda61Biochemistry Department, Faculty of Pharmacy, Heliopolis University, El-Nahda, Ca...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bakr Zaki M, Abulsoud AI, Elsisi AM, Doghish AS, Mansour OAE, Amin AI, Elrebehy MA, Mohamed MY, Goda MA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Metabolic Syndrome (MetS) miR-486-5p miR-497 miR509-5p miR-605 Metabolic Syndrome Index (MSI). Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/f4523351f0cc4e7296ee3f3244025424
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f4523351f0cc4e7296ee3f3244025424
record_format	dspace
spelling	oai:doaj.org-article:f4523351f0cc4e7296ee3f32440254242021-12-02T02:50:46ZPotential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients1178-7007https://doaj.org/article/f4523351f0cc4e7296ee3f32440254242019-05-01T00:00:00Zhttps://www.dovepress.com/potential-role-of-circulating-micrornas-486-5p-497-509-5p-and-605-in-m-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Mohamed Bakr Zaki,1 Ahmed Ibrahim Abulsoud,1,2 Ahmed Mohamed Elsisi,2,3 Ahmed Soliman Doghish,2,4 Ossama Abd Elmotaal Mansour,2 Ashraf Ismail Amin,5 Mahmoud Ahmed Elrebehy,4 Mohamed Yousef Mohamed,6 Mohamed Ahmed Goda61Biochemistry Department, Faculty of Pharmacy, Heliopolis University, El-Nahda, Cairo Governorate 11777, Egypt; 2Biochemistry Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, 13465, Egypt; 3Biochemistry Department, Faculty of Pharmacy, Nahda University, Beni-Suef, Egypt; 4Biochemistry Department, Faculty of Pharmacy, Badr University in Cairo, Badr City, Cairo, Egypt; 5Department of Chemical and Clinical Pathology, National Institute of Diabetes and Endocrinology, Kasr El Ainy, Cairo, Egypt; 6Clinical Pharmacy Department, Faculty of Pharmacy (boys), Al-Azhar University, Nasr City, Cairo 13465, EgyptObjective: This study aims to evaluate the expression pattern of circulating microRNAs (miR)-486-5p, miR-497, miR-509-5p, and miR-605 in the serum of metabolic syndrome (MetS) Egyptian male patients.Methods: In this study, the circulating miR-486-5p, miR-497, miR509-5p, and miR-605 were amplified and quantitatively detected by quantitative real-time polymerase chain reaction in sera of 55 MetS male patients in comparison to 20 male controls. The level of fasting plasma glucose and triacylglycerol (TAG) were measured using calorimetric assay. Blood pressure was measured using mercuric sphygmomanometer. Anthropometric measurements were done to each individual. Furthermore, MetS patients were defined according to the criteria proposed by the American Heart Association and divided into three groups according to MetS index.Results: The study was performed on three groups and a control group defined as follows: group 1: 15 MetS patients who fulfilled all diagnostic criteria of MetS; group 2: 20 MetS patients with normal blood pressure; group 3: 20 MetS patients with normal TAG levels.The levels of miRs are expressed as [median (IQR)]. miR-486-5-p and miR-497 expression were elevated in group 1 [31.9(49), p˂0.0001; 73.1(42.5), p˂0.0001], group 2 [36.4(15.7), p˂0.0001; 68.3(54.8), p˂0.0001], and group (3) [10.8(18.9), p=0.0014; 27.5(39.7), p=0.0012]. MiR-509-5p was elevated in groups 1 and 2 [501(468), p=0.0001], [309(436), p=0.0006], respectively, while normally expressed in group 3 [0.93(0.077), p=0.0001]. miR-605 was elevated in groups 1 and 3 [25.4(20.0), p=0.0018], [54.8(65.8), p˂0.0001], while normally expressed in group 2 [0.84(0.67), p˂0.0001].Conclusion: miRs (486-5p, 497, 509-5p, and 605) serum levels were higher in MetS patients than in healthy control subjects; therefore, these serum miRs can serve as early biomarkers and can be used to follow-up the prognosis of MetS.Keywords: metabolic syndrome (MetS), miR-486-5p, miR-497, miR509-5p, miR-605, metabolic syndrome index (MSI)Bakr Zaki MAbulsoud AIElsisi AMDoghish ASMansour OAEAmin AIElrebehy MAMohamed MYGoda MADove Medical PressarticleMetabolic Syndrome (MetS)miR-486-5pmiR-497miR509-5pmiR-605Metabolic Syndrome Index (MSI).Specialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 12, Pp 601-611 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Metabolic Syndrome (MetS) miR-486-5p miR-497 miR509-5p miR-605 Metabolic Syndrome Index (MSI). Specialties of internal medicine RC581-951
spellingShingle	Metabolic Syndrome (MetS) miR-486-5p miR-497 miR509-5p miR-605 Metabolic Syndrome Index (MSI). Specialties of internal medicine RC581-951 Bakr Zaki M Abulsoud AI Elsisi AM Doghish AS Mansour OAE Amin AI Elrebehy MA Mohamed MY Goda MA Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients
description	Mohamed Bakr Zaki,1 Ahmed Ibrahim Abulsoud,1,2 Ahmed Mohamed Elsisi,2,3 Ahmed Soliman Doghish,2,4 Ossama Abd Elmotaal Mansour,2 Ashraf Ismail Amin,5 Mahmoud Ahmed Elrebehy,4 Mohamed Yousef Mohamed,6 Mohamed Ahmed Goda61Biochemistry Department, Faculty of Pharmacy, Heliopolis University, El-Nahda, Cairo Governorate 11777, Egypt; 2Biochemistry Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, 13465, Egypt; 3Biochemistry Department, Faculty of Pharmacy, Nahda University, Beni-Suef, Egypt; 4Biochemistry Department, Faculty of Pharmacy, Badr University in Cairo, Badr City, Cairo, Egypt; 5Department of Chemical and Clinical Pathology, National Institute of Diabetes and Endocrinology, Kasr El Ainy, Cairo, Egypt; 6Clinical Pharmacy Department, Faculty of Pharmacy (boys), Al-Azhar University, Nasr City, Cairo 13465, EgyptObjective: This study aims to evaluate the expression pattern of circulating microRNAs (miR)-486-5p, miR-497, miR-509-5p, and miR-605 in the serum of metabolic syndrome (MetS) Egyptian male patients.Methods: In this study, the circulating miR-486-5p, miR-497, miR509-5p, and miR-605 were amplified and quantitatively detected by quantitative real-time polymerase chain reaction in sera of 55 MetS male patients in comparison to 20 male controls. The level of fasting plasma glucose and triacylglycerol (TAG) were measured using calorimetric assay. Blood pressure was measured using mercuric sphygmomanometer. Anthropometric measurements were done to each individual. Furthermore, MetS patients were defined according to the criteria proposed by the American Heart Association and divided into three groups according to MetS index.Results: The study was performed on three groups and a control group defined as follows: group 1: 15 MetS patients who fulfilled all diagnostic criteria of MetS; group 2: 20 MetS patients with normal blood pressure; group 3: 20 MetS patients with normal TAG levels.The levels of miRs are expressed as [median (IQR)]. miR-486-5-p and miR-497 expression were elevated in group 1 [31.9(49), p˂0.0001; 73.1(42.5), p˂0.0001], group 2 [36.4(15.7), p˂0.0001; 68.3(54.8), p˂0.0001], and group (3) [10.8(18.9), p=0.0014; 27.5(39.7), p=0.0012]. MiR-509-5p was elevated in groups 1 and 2 [501(468), p=0.0001], [309(436), p=0.0006], respectively, while normally expressed in group 3 [0.93(0.077), p=0.0001]. miR-605 was elevated in groups 1 and 3 [25.4(20.0), p=0.0018], [54.8(65.8), p˂0.0001], while normally expressed in group 2 [0.84(0.67), p˂0.0001].Conclusion: miRs (486-5p, 497, 509-5p, and 605) serum levels were higher in MetS patients than in healthy control subjects; therefore, these serum miRs can serve as early biomarkers and can be used to follow-up the prognosis of MetS.Keywords: metabolic syndrome (MetS), miR-486-5p, miR-497, miR509-5p, miR-605, metabolic syndrome index (MSI)
format	article
author	Bakr Zaki M Abulsoud AI Elsisi AM Doghish AS Mansour OAE Amin AI Elrebehy MA Mohamed MY Goda MA
author_facet	Bakr Zaki M Abulsoud AI Elsisi AM Doghish AS Mansour OAE Amin AI Elrebehy MA Mohamed MY Goda MA
author_sort	Bakr Zaki M
title	Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients
title_short	Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients
title_full	Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients
title_fullStr	Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients
title_full_unstemmed	Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients
title_sort	potential role of circulating micrornas (486-5p, 497, 509-5p and 605) in metabolic syndrome egyptian male patients
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/f4523351f0cc4e7296ee3f3244025424
work_keys_str_mv	AT bakrzakim potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients AT abulsoudai potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients AT elsisiam potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients AT doghishas potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients AT mansouroae potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients AT aminai potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients AT elrebehyma potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients AT mohamedmy potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients AT godama potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients
_version_	1718402138479001600

Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients

Ejemplares similares